Kiniksa Pharmaceuticals Stock (NASDAQ:KNSA), Quotes and News Summary

Q: What sector and industry does Kiniksa Pharmaceuticals (KNSA) operate in?

Kiniksa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Kiniksa Pharmaceuticals Stock (NASDAQ: KNSA) stock price, news, charts, stock research, profile.

Open	$19.560
Close	-
Volume / Avg.	57.599K / 385.882K
Day Range	19.350 - 19.750
52 Wk Range	10.645 - 22.090
Market Cap	$1.388B
P/E Ratio	149.231
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	10.34%
Days to Cover	9.17

Recent News

Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Longboard Pharmaceuticals, Inc.

Avi Kapoor

Crude Oil Up 1%; Verizon Earnings Beat Views

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Tuesday. The Dow traded up 0.28% to 35,510.96 while the NASDAQ rose 0.91% to 14,187.05. The S&P 500, also rose, gaining, 0.48% to 4,576.60.

Lisa Levin

Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers Aurora Acquisition Corp. (NASDAQ: AURC) shares jumped 192% to $30.54.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Jan

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Kiniksa Pharmaceuticals (KNSA) stock?

You can purchase shares of Kiniksa Pharmaceuticals (NASDAQ: KNSA) through any online brokerage.

View our list of the best stock brokerages.

Who are Kiniksa Pharmaceuticals's (KNSA) competitors?

Other companies in Kiniksa Pharmaceuticals’s space includes: Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT), Prothena Corp (NASDAQ:PRTA), Immatics (NASDAQ:IMTX) and Day One Biopharmaceutical (NASDAQ:DAWN).

What is the target price for Kiniksa Pharmaceuticals (KNSA) stock?

The latest price target for Kiniksa Pharmaceuticals (NASDAQ: KNSA) was reported by JP Morgan on Wednesday, May 1, 2024. The analyst firm set a price target for 30.00 expecting KNSA to rise to within 12 months (a possible 53.37% upside). 4 analyst firms have reported ratings in the last year.

Current Stock Price for Kiniksa Pharmaceuticals (KNSA)?

The stock price for Kiniksa Pharmaceuticals (NASDAQ: KNSA) is $19.56 last updated Today at May 2, 2024 at 11:27 AM EDT.

Does Kiniksa Pharmaceuticals (KNSA) pay a dividend?

There are no upcoming dividends for Kiniksa Pharmaceuticals.

When is Kiniksa Pharmaceuticals (NASDAQ:KNSA) reporting earnings?

Kiniksa Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, July 23, 2024.

Is Kiniksa Pharmaceuticals (KNSA) going to split?

There is no upcoming split for Kiniksa Pharmaceuticals.

What sector and industry does Kiniksa Pharmaceuticals (KNSA) operate in?

Kiniksa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-